Tech transfer at risk: The imperative for digital maturity and modernization
Does your organization fully recognize the role that tech transfer plays in linking the design of manufacturing processes with the production of therapeutics?
Configurable, scalable and GxP-compliant solutions to meet the evolving needs of drug development
In today’s digitally-driven era of drug development, life science organizations are eager to leverage digital transformation and AI to achieve faster, data-driven decision-making, accelerate their lab processes and shorten time to market.
IDBS provides tools to capture scientific data at execution, automate business and laboratory processes, and integrate experiment, product and process data throughout the drug development lifecycle, to curate complete, comprehensive AI-ready datasets. Our solutions empower drug development teams to conduct retrospective analysis and utilize predictive analytics, ensuring your drug development process is in control.
Does your organization fully recognize the role that tech transfer plays in linking the design of manufacturing processes with the production of therapeutics?
Many scientists spend time making data useable. Prioritize clean data — whether you store it on paper, in the cloud or in ancient scrolls.
Could digital transformation hold the key to streamlining tech transfers, optimizing process control and reducing costly delays?